Chronic rhinosinusitis with nasal polyps is among our most challenging diagnoses to treat, because these patients essentially have chronic, lifelong inflammation that needs chronic, lifelong treatment, says Benjamin Bleier, a sinus surgeon at the Massachusetts Eye and Ear Hospital and an assistant professor of otolaryngology at Harvard Medical School.

Some of the inflammation in chronic rhinosinusitis with nasal polyps seems to arise when the nasal lining overexpresses P-glycoprotein (a protein pump), leading to over-secretion of inflammatory cytokines. Verapamil blocks P-glycoprotein and, in some patients with chronic rhinosinusitis and nasal polyps, dramatically improves symptom scores, according to a new study.

While the study involving 18 patients is too small to confirm efficacy, the improvement in several outcome measures suggest that verapamil should be assessed further at a higher dose. “We observed no significant side-effects at the doses we used, and we were very encouraged by the results of this first step,” says Dr Bleier.

(J Allergy Clin Immunol DOI: 10.1016/j.jaci.2016.11.014)


Quadrivalent flu jab launched

Sanofi Pasteur recently launched a quadrivalent influenza vaccine in the UK that protects against two A and two B strain...

New antibiotic launched

Pfizer has launched Zavicefta (ceftazidime-avibactam) for adults hospitalised with serious infections


Price concession delays added to contractor stress

Not all of the requested concession prices for the November dispensing month have been granted, says PSNC

Half of Brits take prescription drugs daily

Almost half of UK adults have taken at least one prescribed medicine in the last week, according to a new survey commiss...

Link between physical activity and wellbeing

A clear link between physical activity and mental wellbeing has been proven by a Sport England survey.